Search

You searched for "epithelial"

577 results found

Outcomes of ‘treat and extend’ for neovascular AMD

1 August 2015 | | Retina / Uvea / Vitreous
The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...

Results after 1.4mm biaxial cataract surgery and implantation of a new aspheric intraocular lens

1 April 2015 | | Cataract and Refractive
The aim of this study was to analyse the clinical outcome and higher-order aberrations (HOAs) after 1.4mm biaxial micro incision cataract surgery (B-MICS) and implantation of a new aspheric intraocular lens (IOL). A total of 157 eyes of 106 patients...

SLT vs. topical treatment with prostaglandin analogues in the management of PACG

1 April 2015 | | Glaucoma
Selective laser trabeculoplasty (SLT) has been shown to be useful in the management of primary open angle glaucoma (POAG), but its use in primary angle closure (PAC) / primary angle closure glaucoma (PACG) has yet to be validated. Narayanaswamy et...

Visual recovery following Ex-Press vs. trab

1 April 2015 | | Glaucoma
The authors describe a prospective randomised study of 64 POAG subjects with controlled IOPs comparing visual acuity data in patients randomised to either Ex-Press model P50 or trabeculectomy. Visual acuities were recorded at baseline, day one, weeks one and two...

Aqueous humour cytokine levels in PCV and nAMD

1 April 2015 | | Retina / Uvea / Vitreous
This study looks into the possible roles of various cytokines or growth factors in the pathogenesis of exudative age-related macular degeneration (AMD) by comparing aqueous levels of 14 cytokines between eyes with polypoidal choroidal vasculopathy (PCV) and those with neovascular...

Accelerated (9mW/cm2) corneal collagen cross-linking for keratoconus

1 December 2014 | | Cornea / External Eye Disease, Ocular Pathology and Oncology
This is one of many studies published / to be published on corneal collagen cross-linking that has a treatment time of 10 minutes compared to the previous Dresden protocol of 30 minutes to halt progression of keratoconus. Much has changed...

Cancer associated retinopathy

7 December 2020 | | Ophthalmology, Retina / Uvea / Vitreous
Abdul Muhyemin Tarin reviews the presentation, pathophysiology and management of this paraneoplastic syndrome. Case presentation A 60-year-old hypermetropic female patient presented with several months’ history of painless blurred vision. Visual acuity (VA) was 6/24 and 6/9-1 in right and left...

Advances in the understanding, diagnostic and treatment of keratoconus

1 December 2022 | | Ophthalmology
*Joint first authors Keratoconus is a bilateral and asymmetric eye condition in which the cornea’s structure is affected and thinned, causing a cone-shaped bulge to develop. This results in progressive loss of vision and impairs the ability of the eye...

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

1 October 2018 | | Ophthalmology
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...

The science of glaucoma management: highlights of the 2020 Moorfields International Glaucoma Symposium

5 October 2020 | | Ophthalmology, Glaucoma
Held earlier this year, the 12th annual Moorfields International Glaucoma Symposium provided a forum for advanced clinical and scientific exchange in glaucoma management. The authors describe the key presentation themes and debates, highlighting specific topics of interest to glaucoma specialists....

Treatment of diabetic macular oedema

1 June 2014 | | Retina / Uvea / Vitreous
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

What’s next in retinal imaging? Faster, deeper and full-on

1 April 2015 | | Retina / Uvea / Vitreous, Imaging
Fast-evolving technological leaps are opening the way toward clinically useful ocular coherence angiography, generating 3-dimensional microvasculature maps without intravenous dye injection, as well as whole-eye imaging, handheld patient-operated optical coherence tomography (OCT) devices and, for challenging vitreoretinal procedures, integrated intraoperative...